Nexalin Technology, Inc. ( NXL) - Key Metrics
NXL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.02 | -$3.18 | -$2.56 | -$2.56 |
| 2026Q1 | $0.02 | -$3.17 | -$2.59 | -$2.67 |
| 2025Q4 | $0.28 | -$3.83 | -$1.85 | -$1.90 |
| 2025Q3 | $0.03 | -$3.84 | -$2.47 | -$2.47 |
| 2025Q2 | $0.13 | -$3.02 | -$1.75 | -$1.75 |
NXL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.75 |
| 2026Q1 | 0% | -0.79 |
| 2025Q4 | 0% | -1.07 |
| 2025Q3 | 0% | -1.76 |
| 2025Q2 | 0% | -2.47 |
NXL
Price: $3.63
52 week price:
Earnings Per Share: -13.85 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Market Capitalization: 3.4 million